University of Chicago Comprehensive Cancer Center at Silver Cross Hospital is a clinical research site located in New Lenox, Illinois, United States 60451.
Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Chicago Comprehensive Cancer Center at Silver Cross Hospital has participated in 15 clinical trials with 7 currently active.
Therapeutic areas: Breast Cancer, Non-Small Cell Lung Cancer, Triple-negative Breast Cancer.
Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer, Dana-Farber Cancer Institute.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Illinois · View every site in New Lenox
Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Chicago Comprehensive Cancer Center at Silver Cross Hospital has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Chicago Comprehensive Cancer Center at Silver Cross Hospital has 15 clinical trials on record, with 7 currently active. Their work covers Breast Cancer, Non-Small Cell Lung Cancer, Triple-negative Breast Cancer.
University of Chicago Comprehensive Cancer Center at Silver Cross Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.